Product Description
Ceritinib Spexib Capsules Specification:
- Brand Name: Spexib
- Active Ingredients: Ceritinib
- Manufacturer: Novartis Pharma Stein AG
- Form: Capsules
- Strength: 150 mg
- Packing: 5*10 capsules
Targeted Therapy for ALK-Positive NSCLCSpexib capsules are approved for treating adults diagnosed with ALK-positive Non-Small Cell Lung Cancer. Their targeted mechanism of action helps to inhibit the abnormal ALK protein, resulting in the containment of cancer cell growth and progression. Used in accordance with a physicians guidance, Spexib provides a focused approach to cancer treatment that prioritizes efficacy and safety.
Ease of Oral Administration and StorageSpexib comes in easy-to-swallow, white to off-white opaque hard gelatin capsules with distinct blue printing, packaged in HDPE bottles for optimal protection. With oral administration, the capsules simplify medication routines for patients, while storage below 30C in a dry, light-protected place ensures the product remains potent and safe for use throughout its 24-month shelf life.
FAQs of Spexib capsules:
Q: How should Spexib capsules be taken for cancer treatment?
A: Spexib capsules are administered orally, usually once daily, as directed by a medical professional. It is essential to follow your oncologists instructions on dosage and timing for optimal therapeutic effect.
Q: What is the main benefit of using Spexib for ALK-positive NSCLC?
A: Spexib provides targeted therapy by inhibiting the ALK protein, which plays a key role in the development and spread of certain lung cancers. This specificity offers effective management for patients with ALK-positive NSCLC.
Q: When is Spexib indicated in cancer therapy?
A: Spexib is indicated for the treatment of patients diagnosed with ALK-positive Non-Small Cell Lung Cancer. Use is based on the confirmation of ALK gene mutation and physician recommendation.
Q: Where should Spexib capsules be stored to maintain their efficacy?
A: Store Spexib capsules below 30C, in a dry location and protected from direct light. Keeping them in their original HDPE container inside the carton helps preserve their quality and potency.
Q: What side effects may occur with Spexib treatment?
A: Spexib may cause nausea, diarrhea, vomiting, or liver dysfunction. Its important to monitor for symptoms and communicate concerns to your healthcare provider for proper management.
Q: Who should avoid using Spexib capsules?
A: Spexib is contraindicated in individuals with known hypersensitivity to ceritinib or any of the excipients included in the formulation. Always consult with your physician before starting therapy.
Q: What is the process for obtaining Spexib in India?
A: Spexib is distributed, exported, and traded by Natco Pharma Ltd in India and is available only by prescription. Patients must consult their oncologist to determine eligibility and receive approval for use.